Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay L Hess

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Annual Review of Pathology|October 25, 2011
The pathogenesis of mixed-lineage leukemiaAndrew G Muntean, Jay L Hess
Cancer Cell|June 10, 2008
MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?Andrew G Muntean, Jay L Hess
Current Opinion in Hematology|June 4, 2016
Deregulation of the HOXA9/MEIS1 axis in acute leukemiaCailin T Collins, Jay L Hess
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2004
Fusion-protein truncation provides new insights into leukemogenesisJay L Hess, Bruce A Hug
Cancer Cell|April 18, 2006
Structural basis of multimer-mediated mayhemKajal V Sitwala, Jay L Hess
Archives of Pathology & Laboratory Medicine|October 7, 2010
Acute myeloid leukemia diagnosis in the 21st centuryBryan L Betz, Jay L Hess
ACS Chemical Biology|December 16, 2006
MLL core components give the green light to histone methylationBrendan D Crawford, Jay L Hess
The American Journal of Pathology|September 1, 2009
Epigenetic dysregulation in cancerAndrew G Muntean, Jay L Hess
Cell Research|November 12, 2016
A new target for differentiation therapy in AMLPeilin Ma, Weihua Song, Jay L Hess
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Chromatin immunoprecipitation (ChIP) for analysis of histone modifications and chromatin-associated proteinsThomas A Milne, Keji Zhao, Jay L Hess
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Annual Review of Pathology|October 25, 2011
The pathogenesis of mixed-lineage leukemiaAndrew G Muntean, Jay L Hess
Cancer Cell|June 10, 2008
MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?Andrew G Muntean, Jay L Hess
Current Opinion in Hematology|June 4, 2016
Deregulation of the HOXA9/MEIS1 axis in acute leukemiaCailin T Collins, Jay L Hess
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2004
Fusion-protein truncation provides new insights into leukemogenesisJay L Hess, Bruce A Hug
Cancer Cell|April 18, 2006
Structural basis of multimer-mediated mayhemKajal V Sitwala, Jay L Hess
Archives of Pathology & Laboratory Medicine|October 7, 2010
Acute myeloid leukemia diagnosis in the 21st centuryBryan L Betz, Jay L Hess
ACS Chemical Biology|December 16, 2006
MLL core components give the green light to histone methylationBrendan D Crawford, Jay L Hess
The American Journal of Pathology|September 1, 2009
Epigenetic dysregulation in cancerAndrew G Muntean, Jay L Hess
Cell Research|November 12, 2016
A new target for differentiation therapy in AMLPeilin Ma, Weihua Song, Jay L Hess
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Chromatin immunoprecipitation (ChIP) for analysis of histone modifications and chromatin-associated proteinsThomas A Milne, Keji Zhao, Jay L Hess
Pageof 7